{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:48:42Z","timestamp":1793998122947,"version":"4.8.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background and purpose<\/jats:title>\n<jats:p>Bacterial infections represent a major cause of morbidity and mortality in cirrhotic patients. Our aim was to assess the incidence of bacterial infections, in particular due to multidrug-resistant organisms (MDROs) before and after the introduction of the antimicrobial stewardship program, \u201cStewardship Antimicrobial in VErona\u201d (SAVE). In addition, we also analysed the liver complications and the crude mortality during the whole follow up.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We analysed 229 cirrhotic subjects without previous hospitalization for infections enrolled at the University Verona Hospital from 2017 to 2019 and followed up until December 2021 (mean follow-up 42.7 months).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>101 infections were recorded and 31.7% were recurrent. The most frequent were sepsis (24.7%), pneumonia (19.8%), spontaneous bacterial peritonitis (17.8%). 14.9% of infections were sustained by MDROs. Liver complications occurred more frequently in infected patients, and in case of MDROs infections with a significantly higher MELD and Child-Pugh score. In Cox regression analysis, mortality was associated with age, diabetes and bacterial infections episodes (OR 3.30, CI 95%: (1.63\u20136.70). Despite an increase in total infections over the past three years, a decrease in the incidence rate in MDROs infections was documented concurrently with the introduction of SAVE (IRD 28.6; 95% CI: 4.6\u201352.5, p = 0.02).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our study confirms the burden of bacterial infections in cirrhotic patients, especially MDROs, and the strong interconnection with liver complications. The introduction of SAVE decreased MDROs infections. Cirrhotic patients require a closer clinical surveillance to identify colonized patients and avoid the horizontal spread of MDROs in this setting.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0281813","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T18:25:58Z","timestamp":1676571958000},"page":"e0281813","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-4176","authenticated-orcid":true,"given":"Andrea","family":"Dalbeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4657-0784","authenticated-orcid":true,"given":"Anna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2391-1689","authenticated-orcid":true,"given":"Mirko","family":"Zoncap\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Cattazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Paon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Ieluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Azzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Carrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4933-7718","authenticated-orcid":true,"given":"David","family":"Sacerdoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"pone.0281813.ref001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"G D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"pone.0281813.ref002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhep.2013.10.023","article-title":"The clinical course of cirrhosis. Population based studies and the need of personalized medicine","volume":"60","author":"G. D\u2019Amico","year":"2014","journal-title":"J Hepatol"},{"key":"pone.0281813.ref003","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/liv.13645","article-title":"Infections complicating cirrhosis","volume":"38","author":"S Piano","year":"2018","journal-title":"Liver International"},{"key":"pone.0281813.ref004","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2010.342","article-title":"Potential precipitating factors of esophageal variceal bleeding: A case-control study","volume":"106","author":"WC Liao","year":"2011","journal-title":"American Journal of Gastroenterology"},{"key":"pone.0281813.ref005","first-page":"514","article-title":"Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis","volume":"20","author":"K Mumtaz","year":"2010","journal-title":"J Coll Physicians Surg Pak"},{"key":"pone.0281813.ref006","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.mcna.2009.03.009","article-title":"Hepatic Encephalopathy: Pathophysiology and Emerging Therapies","volume":"93","author":"V Sundaram","year":"2009","journal-title":"Medical Clinics of North America"},{"key":"pone.0281813.ref007","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.24418","article-title":"Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis","volume":"54","author":"A Berzigotti","year":"2011","journal-title":"Hepatology"},{"key":"pone.0281813.ref008","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"P Angeli","year":"2018","journal-title":"J Hepatol"},{"key":"pone.0281813.ref009","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013","volume":"60","author":"R Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"pone.0281813.ref010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"M Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"pone.0281813.ref011","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure","volume":"64","author":"J Cl\u00e0ria","year":"2016","journal-title":"Hepatology"},{"key":"pone.0281813.ref012","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"V Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"pone.0281813.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.94416","article-title":"Microbiota, cirrhosis, and the emerging oral-gut-liver axis","volume":"2","author":"C Acharya","year":"2017","journal-title":"JCI Insight"},{"key":"pone.0281813.ref014","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune Dysfunction and Infections in Patients With Cirrhosis","volume":"9","author":"AR Bonnel","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"pone.0281813.ref015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features","volume":"45","author":"S Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"pone.0281813.ref016","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"J Fern\u00e1ndez","year":"2019","journal-title":"J Hepatol"},{"key":"pone.0281813.ref017","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide","volume":"156","author":"S Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"pone.0281813.ref018","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.jhep.2020.11.010","article-title":"Management of bacterial and fungal infections in cirrhosis: The MDRO challenge","volume":"75","author":"J Fern\u00e1ndez","year":"2021","journal-title":"J Hepatol"},{"key":"pone.0281813.ref019","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"Second infections independently increase mortality in hospitalized patients With cirrhosis: The north American Consortium for the study of end-stage liver disease (NACSELD) experience","volume":"56","author":"JS Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"pone.0281813.ref020","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.28332","article-title":"An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial","volume":"63","author":"M Merli","year":"2016","journal-title":"Hepatology"},{"key":"pone.0281813.ref021","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study","volume":"55","author":"J Fern\u00e1ndez","year":"2012","journal-title":"Hepatology"},{"key":"pone.0281813.ref022","article-title":"Patient Safety and Quality: An Evidence\u2010Based Handbook for Nurses","author":"RG Hughes","year":"2008","journal-title":"Rockville (MD): Agency for Healthcare Research and Quality (US)"},{"key":"pone.0281813.ref023","doi-asserted-by":"crossref","first-page":"106672","DOI":"10.1016\/j.ijantimicag.2022.106672","article-title":"How to \u2018SAVE\u2019 antibiotics: effectiveness and sustainability of a new model of antibiotic stewardship intervention in the internal medicine area","author":"E Carrara","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"pone.0281813.ref024","article-title":"Stepwise regression","volume":"1\u20130","author":"MS Lewis-Beck","year":"2004","journal-title":"The SAGE Encyclopedia of Social Science Research Methods"},{"key":"pone.0281813.ref025","first-page":"32","article-title":"Bacterial infections in cirrhotic patients in a tertiary care hospital","volume":"9","author":"VA Lingiah","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"pone.0281813.ref026","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1093\/cid\/ciz021","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","author":"LE Nicolle","year":"2019","journal-title":"Clinical Infectious Diseases"},{"key":"pone.0281813.ref027","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4254\/wjh.v4.i5.158","article-title":"Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis","volume":"4","author":"C Bunchorntavakul","year":"2012","journal-title":"World J Hepatol"},{"key":"pone.0281813.ref028","doi-asserted-by":"crossref","first-page":"100719","DOI":"10.1016\/j.aohep.2022.100719","article-title":"Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany","volume":"27","author":"WM Kremer","year":"2022","journal-title":"Ann Hepatol"},{"key":"pone.0281813.ref029","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2147\/IDR.S283723","article-title":"Treatment of Hospital-Acquired Infections in Patients with Cirrhosis\u2013New Challenges","volume":"15","author":"DG Maindad","year":"2022","journal-title":"Infect Drug Resist"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T18:26:26Z","timestamp":1676571986000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281813"}},"subtitle":[],"editor":[{"given":"Iddya","family":"Karunasagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0281813","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]}}}